Patents by Inventor David Hammerbeck

David Hammerbeck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070292456
    Abstract: Pharmaceutical formulations in an aqueous (preferably, sprayable) formulation including an immune response modifier (IRM), such as those chosen from imidazoquinoline amines, tetrahydroimidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, 1,2-bridged imidazoquinoline amines, imidazonaphthyridine amines, imidazotetrahydronaphthyridine amines, oxazoloquinoline amines, thiazoloquinoline amines, oxazolopyridine amines, thiazolopyridine amines, oxazolonaphthyridine amines, thiazolonaphthyridine amines, and 1H-imidazo dimers fused to pyridine amines, quinoline amines, tetrahydroquinoline amines, naphthyridine amines, or tetrahydronaphthyridine amines, are provided. In one embodiment, the aqueous formulations are advantageous for treatment and/or prevention of allergic rhinitis, viral infections, sinusitis, and asthma.
    Type: Application
    Filed: August 5, 2004
    Publication date: December 20, 2007
    Applicant: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: David Hammerbeck, Cynthia Guy, Suzanne Leung
  • Publication number: 20050226878
    Abstract: The present invention provides therapeutic combinations that include an immune response modifier (IRM) component and an anti-inflammatory component. The inventions further provide methods of treating a condition by administering to one having the condition a therapeutic combination that includes an IRM component and an anti-inflammatory component.
    Type: Application
    Filed: June 1, 2005
    Publication date: October 13, 2005
    Inventors: Mark Tomai, Gary Gullikson, David Hammerbeck, Elaine Egging, Michael Reiter, Christopher Gram, John Vasilakos, Sefik Alkan
  • Publication number: 20050171072
    Abstract: The present invention provides therapeutic combinations that include an immune response modifier (IRM) component and an anti-inflammatory component. The inventions further provide methods of treating a condition by administering to one having the condition a therapeutic combination that includes an IRM component and an anti-inflammatory component.
    Type: Application
    Filed: December 2, 2004
    Publication date: August 4, 2005
    Inventors: Mark Tomai, Gary Gullikson, David Hammerbeck, Elaine Egging, Michael Reiter, Christopher Gram, John Vasilakos
  • Publication number: 20050158325
    Abstract: The present invention provides immunomodulatory combinations that includes an IRM component and a therapeutic agent, each in an amount that, when in combination with the other, is effective for inducing an immune response in a subject.
    Type: Application
    Filed: December 30, 2004
    Publication date: July 21, 2005
    Inventors: David Hammerbeck, Ross Kedl, Richard Miller, Mark Tomai, John Vasilakos
  • Publication number: 20050070460
    Abstract: The present invention provides methods of providing prophylaxis to a subject against an infectious agent. In general, the methods include topically administering to the respiratory tract of a subject an IRM compound in an amount effective to reduce infection by the agent.
    Type: Application
    Filed: August 5, 2004
    Publication date: March 31, 2005
    Inventors: David Hammerbeck, Cynthia Guy